Physician profile
Steve Wilson
NPI 1437263282
$1,793.33
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,189 · 2020: $319 · 2021: $149 · 2022: $77.00 · 2023: $40.29 · 2024: $19.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $59.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $59.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medinc of Texas | $945.00 | 2019 | |
| Stryker Corporation | $333.23 | 2020-2022 | |
| Depuy Synthes Sales INC. | $92.36 | 2019-2024 | Monovisc |
| Amgen INC. | $76.50 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $73.39 | 2020-2021 | |
| Orthogenrx INC. | $61.02 | 2019 | |
| Ethicon US, LLC | $40.29 | 2023 | Stratafix, Harmonic, Mega Soft |
| Ferring Pharmaceuticals INC. | $39.73 | 2019 | |
| Bioventus LLC | $35.36 | 2022 | |
| Kerecis Limited | $22.68 | 2019 | |
| Pacira Therapeutics, INC. | $17.86 | 2020 | |
| Collegium Pharmaceutical, INC. | $15.70 | 2019 | |
| Smith+Nephew, INC. | $14.87 | 2019 | |
| Endo Pharmaceuticals INC. | $14.24 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.